×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AXGN – axogen, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AXGN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/2
09:57 am
axgn
What Makes Axogen (AXGN) an Investment Bet? [Yahoo! Finance]
Medium
Report
What Makes Axogen (AXGN) an Investment Bet? [Yahoo! Finance]
3/30
11:54 am
axgn
AxoGen (AXGN) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $40.00 price target on the stock.
Low
Report
AxoGen (AXGN) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $40.00 price target on the stock.
3/24
03:30 pm
axgn
Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know [Yahoo! Finance]
Low
Report
Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know [Yahoo! Finance]
3/21
08:23 pm
axgn
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth [Yahoo! Finance]
Medium
Report
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth [Yahoo! Finance]
3/12
11:02 am
axgn
AxoGen Says BLA Approval Secures Avance Use, Boosts Coverage Talks and Reimbursement Momentum [Yahoo! Finance]
Low
Report
AxoGen Says BLA Approval Secures Avance Use, Boosts Coverage Talks and Reimbursement Momentum [Yahoo! Finance]
3/5
09:32 pm
axgn
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference [Yahoo! Finance]
Low
Report
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference [Yahoo! Finance]
2/26
06:33 am
axgn
AxoGen, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
AxoGen, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/25
03:37 pm
axgn
A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations [Yahoo! Finance]
Low
Report
A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/26
04:11 pm
axgn
Form SCHEDULE 13G/A Axogen, Inc. Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A Axogen, Inc. Filed by: VANGUARD GROUP INC
3/18
04:11 pm
axgn
Form 4 Axogen, Inc. For: Mar 16 Filed by: DeVinney Erick Wayne
Low
Report
Form 4 Axogen, Inc. For: Mar 16 Filed by: DeVinney Erick Wayne
3/18
04:10 pm
axgn
Form 4 Axogen, Inc. For: Mar 16 Filed by: Hartley Lindsey Marie
Low
Report
Form 4 Axogen, Inc. For: Mar 16 Filed by: Hartley Lindsey Marie
3/2
06:17 pm
axgn
Form 4 Axogen, Inc. For: Feb 26 Filed by: Kemp Jens
Low
Report
Form 4 Axogen, Inc. For: Feb 26 Filed by: Kemp Jens
3/2
06:16 pm
axgn
Form 4 Axogen, Inc. For: Feb 26 Filed by: DeVinney Erick Wayne
Low
Report
Form 4 Axogen, Inc. For: Feb 26 Filed by: DeVinney Erick Wayne
3/2
06:16 pm
axgn
Form 4 Axogen, Inc. For: Feb 26 Filed by: Began Marc A
Low
Report
Form 4 Axogen, Inc. For: Feb 26 Filed by: Began Marc A
2/27
04:25 pm
axgn
Form 4 Axogen, Inc. For: Feb 26 Filed by: Hartley Lindsey Marie
Low
Report
Form 4 Axogen, Inc. For: Feb 26 Filed by: Hartley Lindsey Marie
2/27
04:23 pm
axgn
Form 4 Axogen, Inc. For: Feb 26 Filed by: DALE MICHAEL D
Low
Report
Form 4 Axogen, Inc. For: Feb 26 Filed by: DALE MICHAEL D
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/6
AxoGen, Inc. (AXGN) CEO Karen Zaderej on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha]
14.0%
2/5 Axogen, Inc. to Present at the Leerink Partners 9th Annual Global Healthcare Conference 10.5%
8/12 Form 4 Axogen, Inc. For: Aug 09 Filed by: Zaderej Karen L. 9.2%
8/16 Form 8-K Axogen, Inc. For: Aug 14 6.8%
6/12 AxoGen, Inc (NASDAQ: AXGN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.4%
12/20 Form 4 Axogen, Inc. For: Dec 18 Filed by: Freitag Gregory Gene 5.6%
8/7 AxoGen (AXGN) Investor Presentation - Slideshow [Seeking Alpha] 5.5%
11/23 Edited Transcript of AXGN earnings conference call or presentation 6-Nov-19 9:30pm GMT [Yahoo! Finance News] 5.1%
8/15 Form 4 Axogen, Inc. For: Aug 09 Filed by: Gold Mark Stephen 4.9%
2/14 Form SC 13G/A Axogen, Inc. Filed by: EW Healthcare Partners, L.P. 4.7%
2/5 Axogen, Inc. to Present at the Leerink Partners 9th Annual Global Healthcare Conference 10.5%
8/12 Form 4 Axogen, Inc. For: Aug 09 Filed by: Zaderej Karen L. 9.2%
8/16 Form 8-K Axogen, Inc. For: Aug 14 6.8%
6/12 AxoGen, Inc (NASDAQ: AXGN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.4%
12/20 Form 4 Axogen, Inc. For: Dec 18 Filed by: Freitag Gregory Gene 5.6%
8/7 AxoGen (AXGN) Investor Presentation - Slideshow [Seeking Alpha] 5.5%
11/23 Edited Transcript of AXGN earnings conference call or presentation 6-Nov-19 9:30pm GMT [Yahoo! Finance News] 5.1%
8/15 Form 4 Axogen, Inc. For: Aug 09 Filed by: Gold Mark Stephen 4.9%
2/14 Form SC 13G/A Axogen, Inc. Filed by: EW Healthcare Partners, L.P. 4.7%
TOP News Decliners
8/6
AxoGen Inc (AXGN) Q2 2019 Earnings Call Transcript [The Motley Fool]
-29.2%
2/24 Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results -17.0%
1/13 Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance -15.3%
1/3 Form 4 Axogen, Inc. For: Jan 01 Filed by: Rudelius Robert James -11.6%
3/2 Axogen, Inc. to Participate at Upcoming Investor Conferences -8.1%
5/16 Form 4 Axogen, Inc. For: May 13 Filed by: Hansen David K -7.8%
1/17 Form 4 Axogen, Inc. For: Jan 01 Filed by: Zaderej Karen L. -7.6%
4/15 Axogen, Inc. to Report First Quarter 2020 Financial Results and Host Conference Call on May 6, 2020 -6.2%
4/29 Form 4 Axogen, Inc. For: Apr 28 Filed by: DeVinney Erick Wayne -4.9%
12/4 Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float -4.8%
2/24 Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results -17.0%
1/13 Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance -15.3%
1/3 Form 4 Axogen, Inc. For: Jan 01 Filed by: Rudelius Robert James -11.6%
3/2 Axogen, Inc. to Participate at Upcoming Investor Conferences -8.1%
5/16 Form 4 Axogen, Inc. For: May 13 Filed by: Hansen David K -7.8%
1/17 Form 4 Axogen, Inc. For: Jan 01 Filed by: Zaderej Karen L. -7.6%
4/15 Axogen, Inc. to Report First Quarter 2020 Financial Results and Host Conference Call on May 6, 2020 -6.2%
4/29 Form 4 Axogen, Inc. For: Apr 28 Filed by: DeVinney Erick Wayne -4.9%
12/4 Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float -4.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: